Scott Thomas Smith

EVP & Chief Financial Officer · 2 filings · Latest: Jun 2, 2026

Ascendis Pharma A/S

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ASND	Scott Thomas Smith	EVP & Chief Financial Officer	Jun 2, 2026	Purchase	$219.00	100	$21.9K	4,367	Jun 2 8:25 PM
ASND	Scott Thomas Smith	EVP & Chief Financial Officer	May 29, 2026	Purchase	$223.32	250	$55.8K	4,267	Jun 1 8:10 PM